Will Hyperliquid Price Set Another All-Time High in Q3 2025?
2025/06/29 12:00HYPE has experienced notable volatility recently, pushing the altcoin upwards. The rise to a new all-time high (ATH) may be delayed.
However, it remains a strong possibility for the coming months, especially with the positive momentum building in the market.
Hyperliquid Is Noting Bullishness
The Relative Strength Index (RSI) for HYPE has made a positive shift, moving back into the bullish zone after briefly slipping below the neutral mark. This rise above 50.0 signals strengthening bullish momentum, which is a promising sign for HYPE’s price in the days ahead.
As the RSI stays above 50.0, it suggests that the upward momentum is gaining traction. Investors can expect HYPE’s price to experience continued upward movement as long as the RSI maintains this bullish trend.
HYPE RSI.
The Moving Average Convergence Divergence (MACD) indicator is also showing promising signs for HYPE. It is on the verge of a bullish crossover, which would confirm the shift in momentum from bearish to bullish.
The histogram associated with the MACD is showing declining red bars, signaling that bearish pressure is waning. A confirmed bullish crossover would confirm the strength of the momentum and fuel HYPE’s rise towards new highs.
HYPE MACD.
HYPE Price Is Nearing The ATH
HYPE is currently trading at $39.1, just under the resistance of $39.9. Breaking through this level is crucial for HYPE to continue its upward trajectory.
Securing $39.9 as support would signal the potential for further gains and set the stage for the altcoin to push toward higher price levels.
To continue its upward trend, HYPE would need to breach and hold $42.2 as support. If successful, the next key target would be the ATH of $45.8, which is approximately 16.8% above the current price.
However, this move might take longer, with investors likely seeing it happen sometime after Q3 begins next week.
HYPE Price Analysis.
Both $42.2 and $39.9 have been critical resistance levels for HYPE.
If the altcoin fails to break through $39.9 or encounters selling pressure before reaching these levels, it could fall back to the support of $35.7, invalidating the bullish outlook and potentially reversing the current trend.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. Stock IPO Preview | From Losses to Net Profit of 5.46 Million: The "Three-Dimensional" Platform Business Strategy with a Taste for Golf
Crossing the break-even line, the growth inflection point has arrived.
Core CPI Exceeds Expectations Again, Fed Hawks Loud! 2027 FOMC Voting Member Directly Calls Inflation Hot
Austan Goolsbee, President of the Chicago Federal Reserve, stated that officials must address the issue of high inflation, and described the October consumer price report as worrisome.
Weight-loss drug receives FDA warning for rare eye disease; Novo Nordisk (NVO.US) and Eli Lilly (LLY.US): No evidence of causality
The FDA requires all GLP-1 drugs to include a warning about the rare eye disease NAION. Novo Nordisk and Eli Lilly deny any causality, while Citi states that the impact on adoption is limited.
